Vaccine Makers Pfizer and Moderna Pledge Massive Boost to U.S. Supply
The pledges come after a sluggish rollout
Today, drug companies told lawmakers they project a major increase in vaccine deliveries that will result in 140 million more doses over the next five weeks, saying they have solved manufacturing challenges and are in a position to overcome scarcity that has hampered the nation’s fight against the coronavirus.
“The United States and every other country needs more doses more quickly,'' John Young, Pfizer’s chief business officer, told members of the House Energy and Commerce oversight and investigations subcommittee.
But achieving a surge on that scale remains daunting. Pfizer and Moderna, the companies with the only authorized vaccines so far, will need to increase their combined deliveries to date of 80 million doses to reach their promised target of 220 million shots by March 31.
Please select this link to read the complete article from The Washington Post.